Fact based stock research
Skilled Healthcare (NYSE:GEN)


Skilled Healthcare stock research in summary

skilledhealthcaregroup.com


Skilled Healthcare shares have a SELL rating. They are bad value, are riskily financed, and show below average growth. We recommend selling Skilled Healthcare shares.


Latest Obermatt Ranks


Country USA
Industry Health Care Facilities
Index D.J. US Health Care
Size class Medium

March 22, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()


Achievements

Top 10 Stock



Research History: Skilled Healthcare

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
39
42
63
40
STOCK GROWTH RANKS
1
31
1
1
STOCK SAFETY RANKS
13
13
35
28
COMBINED STOCK RANKS
1
8
27
1

Last update of Combined Rank: 22-Mar-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better is Skilled Healthcare in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 22-Mar-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Skilled Healthcare; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
65
39
8
8
PROFIT GROWTH
17
58
58
17
STOCK RETURNS
16
58
1
1
CONSOLIDATED RANK: GROWTH
1
31
1
1

Financial reporting date of Growth Rank: 30-Sep-2017. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Skilled Healthcare.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
1
1
1
1
REFINANCING
97
97
97
98
LIQUIDITY
1
2
1
1
CONSOLIDATED RANK: SAFETY
13
13
35
28

Financial reporting date of Safety Rank: 30-Sep-2017. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Skilled Healthcare and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Skilled Healthcare from March 22, 2018.